| Literature DB >> 34072546 |
Vanessa Kohl1, Oliver Drews2, Victor Costina2, Miriam Bierbaum3, Ahmed Jawhar4, Henning Roehl5, Christel Weiss6, Susanne Brendel1, Helga Kleiner1, Johanna Flach1, Birgit Spiess1, Wolfgang Seifarth1, Daniel Nowak1, Wolf-Karsten Hofmann1, Alice Fabarius1, Henning D Popp1.
Abstract
Non-targeted effects (NTE) of ionizing radiation may initiate myeloid neoplasms (MN). Here, protein mediators (I) in irradiated human mesenchymal stromal cells (MSC) as the NTE source, (II) in MSC conditioned supernatant and (III) in human bone marrow CD34+ cells undergoing genotoxic NTE were investigated. Healthy sublethal irradiated MSC showed significantly increased levels of reactive oxygen species. These cells responded by increasing intracellular abundance of proteins involved in proteasomal degradation, protein translation, cytoskeleton dynamics, nucleocytoplasmic shuttling, and those with antioxidant activity. Among the increased proteins were THY1 and GNA11/14, which are signaling proteins with hitherto unknown functions in the radiation response and NTE. In the corresponding MSC conditioned medium, the three chaperones GRP78, CALR, and PDIA3 were increased. Together with GPI, these were the only four altered proteins, which were associated with the observed genotoxic NTE. Healthy CD34+ cells cultured in MSC conditioned medium suffered from more than a six-fold increase in γH2AX focal staining, indicative for DNA double-strand breaks, as well as numerical and structural chromosomal aberrations within three days. At this stage, five proteins were altered, among them IQGAP1, HMGB1, and PA2G4, which are involved in malign development. In summary, our data provide novel insights into three sequential steps of genotoxic signaling from irradiated MSC to CD34+ cells, implicating that induced NTE might initiate the development of MN.Entities:
Keywords: CD34+ cells; genotoxic signals; irradiation; mesenchymal stromal cells; myeloid neoplasms; non-targeted effects
Mesh:
Substances:
Year: 2021 PMID: 34072546 PMCID: PMC8197937 DOI: 10.3390/ijms22115844
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Reactive oxygen species (ROS) levels in irradiated mesenchymal stromal cells (MSC) and CD34+ cells grown in MSC conditioned medium. (A) ROS levels in 2 Gy-irradiated MSC at 4 h after irradiation. n = 8 samples. (B) ROS levels in CD34+ cells grown for 3 days in medium conditioned by 2 Gy-irradiated MSC. n = 5 samples. Data are presented as means ± SEM. fc, fold change. One sample t-tests. * p < 0.05.
Figure 2Non-targeted effects in CD34+ cells. (A) Exemplary immunofluorescence images of γH2AX foci (green, Alexa 488) in nuclei (blue, DAPI) of CD34+ cells grown for 3 days in medium conditioned by 2 Gy-irradiated mesenchymal stromal cells (MSC). Scale bar, 5 µm. (B) γH2AX foci in CD34+ cells grown for 3 days in control medium and MSC conditioned medium. n = 9 samples. (C,D) Exemplary aberrant metaphases of different donor CD34+ cells grown for 3 days in MSC conditioned medium. Scale bar, 10 µm. (E) Exemplary aberrant karyotype of a donor CD34+ cell grown for 3 days in MSC conditioned medium. (F) Viability of CD34+ cells grown for 3 days in control medium and MSC conditioned medium. n = 10 samples. Data in (B,F) are presented as means ± SEM. fc, fold change. Wilcoxon two-sample test. *** p < 0.005.
Non-targeted effects in CD34+ cells. fc, fold change; ISCN, international system for human cytogenetic nomenclature; NA, not assessed; Pt, patient; ROS, reactive oxygen species; [number], number of analyzed metaphases.
| Pt | Age/Sex | ROS Level (fc) Irrad. MSC | ROS Level (fc) CD34+ Cells | γH2AX Foci (fc) per CD34+ Cell Cond. Medium | Cytogenetics (ISCN) CD34+ Cells | Viability (fc) CD34+ Cells | |
|---|---|---|---|---|---|---|---|
| #1 | 90/♂ | NA | NA | 13.0 | 46,XY | 46,XY[20] | 1.0 |
| #2 | 56/♂ | NA | NA | 1.9 | 46,XY | 46,XY[22] | 1.0 |
| #3 | 92/♀ | NA | 1.4 | 10.5 | 46,XX | 46,XX[18] | 0.8 |
| #4 | 58/♀ | NA | NA | 6.9 | 46,XX | 46,XX[19] | 0.9 |
| #5 | 85/♀ | 1.1 | 1.5 | 10.2 | 46,XX | 46,XX[24] | 1.1 |
| #6 | 67/♀ | 1.6 | NA | 2.1 | 46,XX | 46,XX[25] | 1.0 |
| #7 | 77/♂ | 1.9 | NA | 7.1 | 46,XY | 46,XY[21] | NA |
| #8 | 54/♀ | 2.5 | 1.6 | 3.9 | 46,XX | 46,XX[22] | 1.6 |
| #9 | 65/♂ | 1.3 | NA | NA | 46,XY | 46,XY[19] | 1.1 |
| #10 | 58/♀ | 1.8 | NA | 6.3 | 46,XX | 46,XX[20] | NA |
| #11 | 70/♂ | 1.1 | 1.0 | NA | 46,XY | 46,XY[19] | 1.3 |
| #12 | 59/♀ | 2.8 | 0.8 | NA | 46,XX | 46,XX[22] | 1.1 |
Figure 3Comparative proteome analysis in mesenchymal stromal cells (MSC), MSC conditioned medium and CD34+ cells. (A) Exemplary SDS-PAGE of lysates of non-irradiated and 2 Gy-irradiated MSC, (B) control medium and medium conditioned by 2 Gy-irradiated MSC and (C) lysates of CD34+ cells grown in control medium and in medium conditioned by 2 Gy-irradiated MSC. (D) Proteome alterations in mesenchymal stromal cells (MSC) (n = 5 replicates, * 3%), (E) MSC conditioned medium (n = 4 replicates) and (F) CD34+ cells grown for 3 days in MSC conditioned medium (n = 5 replicates).
Proteome data in irradiated mesenchymal stromal cells (MSC) (n = 5 replicates), MSC conditioned medium (n = 4 replicates) and CD34+ cells grown in MSC conditioned medium (n = 5 replicates) in comparison to controls. Gp, group; PSMs, peptide-to-spectrum matches.
| Gp | Category | Accession No. | Protein | Function | Abundance Ratio | Abundance | Coverage | No. of Unique Peptides | PSMs |
|---|---|---|---|---|---|---|---|---|---|
|
| Protein synthesis/ | P46783 | 40S ribosomal protein S10 (RPS10) | 40S ribosomal subunit | 4.3 | <0.0001 | 20 | 2 | 9 |
| O00303 | Eukaryotic translation initiation factor 3 subunit F (eIF3f) | Component of eIF-3 complex | 4.2 | <0.0001 | 13 | 3 | 11 | ||
| Q10713 | Mitochondrial-processing peptidase subunit alpha (PMPCA) | Subunit of essential mitochondrial processing protease | 3.8 | <0.0001 | 6 | 2 | 8 | ||
| Q92616 | eIF-2-alpha kinase activator GCN1 (GCN1) | Complex with EIF2AK4/GCN2 on translating ribosomes | 3.2 | <0.0001 | 6 | 9 | 45 | ||
| P62937 | Peptidyl-prolyl cis-trans isomerase A (PPIA) | Protein folding | 3.1 | 0.0037 | 58 | 9 | 67 | ||
| P61289 | Proteasome activator complex subunit 3 (PA28g) | Proteasome regulator | 2.8 | 0.0101 | 16 | 3 | 3 | ||
| P26368 | Splicing factor U2AF 65 kDa subunit (U2AF2) | pre-mRNA splicing and 3′-end processing | 2.7 | 0.0004 | 20 | 4 | 17 | ||
| Q12849 | G-rich sequence factor 1 (GRSF-1) | Post-transcriptional mitochondrial gene expression | 2.3 | 0.0041 | 11 | 2 | 7 | ||
| Q86VP6 | Cullin-associated NEDD8-dissociated protein 1 (p120 CAND1) | Key assembly factor of SCF E3 ubiquitin ligase complexes | 2.3 | 0.0084 | 9 | 7 | 26 | ||
| P60842 | Eukaryotic initiation factor 4A-(eIF-4A-I) | RNA helicase subunit of eIF4F complex | 2.1 | 0.0114 | 39 | 8 | 63 | ||
| Q5VYK3 | Proteasome adapter and scaffold protein ECM29 (ECM29) | Binds to 26S proteasome | 2.1 | 0.0172 | 1 | 2 | 9 | ||
| P23381 | Tryptophan-tRNA ligase, cytoplasmic (WARS1) | Aminoacylation of tRNA | 2.0 | 0.0156 | 24 | 6 | 15 | ||
| Q10567 | AP-1 complex subunit beta-1 (AP1B1) | Protein sorting in trans-Golgi network and/or endosomes | 2.0 | 0.0278 | 14 | 2 | 57 | ||
| P61513 | 60S ribosomal protein L37a (RPL37A) | 60S ribosomal subunit | 0.39 | 0.0008 | 17 | 2 | 8 | ||
| Cytoskeleton dynamics | P07942 | Laminin subunit beta-1 (LAMB1) | Component of basal membrane | 2.6 | 0.0012 | 5 | 5 | 28 | |
| O75844 | CAAX prenyl protease 1 homolog (ZMPSTE24) | Cleavage of prelamin to lamin A | 2.5 | 0.0027 | 5 | 2 | 4 | ||
| Q14195 | Dihydropyrimidinase-related protein 3 (DRP-3) | Remodeling of cytoskeleton | 2.2 | 0.0054 | 14 | 4 | 17 | ||
| Q01518 | Adenylyl cyclase-associated protein 1 (CAP1) | Regulator of filament dynamics | 2.2 | 0.0070 | 40 | 11 | 66 | ||
| P33176 | Kinesin-1 heavy chain (KIF5B) | Microtubule-dependent motor | 2.1 | 0.0194 | 4 | 2 | 4 | ||
| P08670 | Vimentin (VIM) | Intermediate filaments | 0.29 | <0.0001 | 12 | 4 | 15 | ||
| Nuclear transport | O14980 | Exportin-1 (Exp1) | Nuclear export of proteins and RNA | 5.1 | <0.0001 | 5 | 3 | 11 | |
| Q96P70 | Importin-9 (Imp9) | Nuclear transport receptor | 4.5 | <0.0001 | 4 | 2 | 3 | ||
| Q92621 | Nuclear pore complex protein Nup205 (NUP205) | Component of nuclear pore complex (NPC) | 3.4 | <0.0001 | 4 | 3 | 7 | ||
| P55060 | Exportin-2 (Exp2) | Importin-alpha re-export from nucleus to cytoplasm | 2.5 | 0.0032 | 11 | 6 | 17 | ||
| Metabolic regulation | P00338 | L-lactate dehydrogenase A chain (LDH-A) | Synthesizes (S)-lactate from pyruvate | 3.2 | <0.0001 | 12 | 3 | 6 | |
| O95336 | 6-phosphogluconolactonase (6PGL) | Pentose phosphate pathway | 2.7 | 0.0125 | 11 | 2 | 9 | ||
| Q8N0Y7 | Probable phosphoglycerate mutase 4 (PGAM4) | Glycolysis | 2.6 | 0.0191 | 22 | 4 | 27 | ||
| Oxidative stress defense | P32119 | Peroxiredoxin-2 (PRDX2) | Thiol-specific peroxidase | qualitative | <0.0001 | 23 | 2 | 12 | |
| P09211 | Glutathione S-transferase P (GSTP1-1) | Conjugation of reduced glutathione | 2.4 | 0.0340 | 22 | 3 | 12 | ||
| Cell-cell/matrix interactions | P04216 | Thy-1 membrane glycoprotein (THY1) | Cell-cell and cell-matrix interactions, | 3.9 | 0.0003 | 12 | 3 | 19 | |
| Signaling | O95837/P29992 | Guanine nucleotide-binding protein subunit alpha-11/14 (GNA11/14) | Activation of PLC-β: IP3 → calcium/PKC | 3.8 | <0.0001 | 6 | 2 | 8 | |
|
| Chaperoning/oncogenic signaling | P11021 | Endoplasmic reticulum chaperone BiP (GRP78) | Unfolded protein response (UPR), | 3.5 | 0.0227 | 29 | 13 | 40 |
| P27797 | Calreticulin (CALR) | Calreticulin/calnexin cycle, calcium-binding protein | 2.4 | 0.0036 | 13 | 4 | 19 | ||
| P30101 | Protein disulfide-isomerase A3 (PDIA3) | Rearrangement of -S-S- bonds in proteins | 2.0 | 0.0225 | 21 | 10 | 29 | ||
| Metabolic regulation/oncogenic signaling | P06744 | Glucose-6-phosphate isomerase (GPI)/autocrine motility factor (AMF) | Glycolysis-related enzyme, ligand of AMF receptor | 2.4 | 0.0006 | 9 | 4 | 7 | |
|
| Mitochondrial homeostasis | P36776 | Lon protease homolog, mitochondrial (LONP1) | Degradation of misfolded or damaged polypeptides | 4.1 | <0.0001 | 7 | 2 | 8 |
| Signaling | Q9UQ80 | Proliferation-associated protein 2G4 (PA2G4) | ERBB3 signaling, growth regulation, increased in AML | 2.2 | <0.0001 | 18 | 4 | 4 | |
| Cytoskeleton dynamcis | P46940 | Ras GTPase-activating-like protein IQGAP1 (IQGAP1) | Dynamics and assembly of actin cytoskeleton | 0.48 | <0.0001 | 3 | 2 | 5 | |
| Translation | O00303 | Eukaryotic translation initiation factor 3 subunit F (eIF3f) | Component of eIF-3 complex, decreased in cancers | 0.40 | <0.0001 | 8 | 2 | 12 | |
| Nuclear regulations | P09429 | High mobility group protein B1 (HMGB1) | DNA chaperone, replication, transcription, chromatin remodeling, p38-MAPK/NF-kappa B activation | 0.35 | <0.0001 | 18 | 3 | 5 |
Figure 4Model of the sequence of genotoxic cell-to-cell signaling from irradiated mesenchymal stromal cells (MSC) over released mediators to CD34+ cells. Irradiation of MSC induces (1) DNA damage directly and most likely indirectly by (2) reactive oxygen species (ROS). Detected protein shifts in MSC affected (3) protein synthesis/processing/degradation, (4) cytoskeleton dynamics, (5) nuclear transport, (6) metabolic regulation, (7) oxidative stress defense, (8) cell-cell/matrix interactions, and (9) intracellular signaling. Mediators released from MSC such as (10) chaperones and (11) a metabolic regulator were transmitted to CD34+ cells. In CD34+ cells, the occurrence of DNA damage and chromosomal instability (CIN) (12) was most likely mediated by increased generation of (13) ROS as well as by perturbations in (14) mitochondrial homeostasis, (15) intracellular signaling, (16) cytoskeleton dynamics, (17) translation, and (18) nuclear regulation.
Figure 5Experimental set-up for irradiation of mesenchymal stromal cells (MSC). MSC flasks were placed on 8 × 1 cm plexiglass sheets on the patient table of a Versa HD linear accelerator (Elekta). An additional 1 cm plexiglass sheet was put on top of the flasks. The laser system was used for positioning the flasks in the radiation field. All MSC in the flasks were irradiated with 2 Gy of 6 MV X-rays in orientation from top.